This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of July 2025. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.
| Item | Value |
|---|---|
| Country | |
| Facebook page | HutchinsonCenter |
| Website | https://www.fredhutch.org/en/news/fred-hutch-south-africa.html |
| Twitter username | fredhutch |
| Wikipedia page | https://en.wikipedia.org/wiki/Fred_Hutchinson_Cancer_Research_Center |
| Instagram username | FredHutch |
| Cause area | Count | Median | Mean | Minimum | 10th percentile | 20th percentile | 30th percentile | 40th percentile | 50th percentile | 60th percentile | 70th percentile | 80th percentile | 90th percentile | Maximum |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall | 45 | 1,051,333 | 5,265,596 | -2,595,322 | 0 | 250 | 25,000 | 100,000 | 1,051,333 | 1,884,633 | 3,084,907 | 7,146,511 | 15,144,268 | 63,676,225 |
| Global health | 39 | 1,697,205 | 6,073,226 | -2,595,322 | 0 | 0 | 100,000 | 998,330 | 1,697,205 | 2,609,460 | 4,802,089 | 8,000,000 | 16,175,191 | 63,676,225 |
| 3 | 250 | 333 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 500 | 500 | 500 | 500 | |
| FIXME | 2 | 25,000 | 25,000 | 25,000 | 25,000 | 25,000 | 25,000 | 25,000 | 25,000 | 25,000 | 25,000 | 25,000 | 25,000 | 25,000 |
| Science | 1 | 45,000 | 45,000 | 45,000 | 45,000 | 45,000 | 45,000 | 45,000 | 45,000 | 45,000 | 45,000 | 45,000 | 45,000 | 45,000 |
| Donor | Total | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 1989 | 1986 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation (filter this donee) | 236,855,833.32 | 0.00 | 31,571,505.00 | 90,343,239.00 | 2,609,460.00 | 33,388,590.00 | 11,833,777.00 | 8,998,330.00 | 1,157,694.00 | 0.00 | 100,000.00 | 100,000.00 | 12,279,298.00 | 44,473,940.32 | 0.00 | 0.00 |
| MacArthur Foundation (filter this donee) | 50,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 25,000.00 | 25,000.00 |
| Chan Zuckerberg Initiative (filter this donee) | 45,000.00 | 45,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| DonorsTrust (filter this donee) | 1,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 250.00 | 250.00 | 500.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total | 236,951,833.32 | 45,000.00 | 31,571,505.00 | 90,343,239.00 | 2,609,460.00 | 33,388,590.00 | 11,833,777.00 | 8,998,330.00 | 1,157,694.00 | 250.00 | 100,250.00 | 100,500.00 | 12,279,298.00 | 44,473,940.32 | 25,000.00 | 25,000.00 |
There are no documents associated with this donee.
Graph of top 10 donors (for donations with known year of donation) by amount, showing the timeframe of donations
| Donor | Amount (current USD) | Amount rank (out of 45) | Donation date | Cause area | URL | Influencer | Notes |
|---|---|---|---|---|---|---|---|
| Chan Zuckerberg Initiative | 45,000.00 | 31 | Science | https://chanzuckerberg.com/grants-ventures/grants/ | -- | Program: Human Cell Atlas. Grant period: 2018–2019. This grant supports providing R / Bioconductor software as a coherent programmatic interface to the HCA and to enable scalable interactive statistical analysis of single-cell data. (PI: Raphael Gottardo, Human Cell Atlas Computational Tools RFA). | |
| Bill and Melinda Gates Foundation | 49,815.00 | 30 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to develop methods and computational tools in biostatistics, computational biology, and mathematical modeling that will improve the quantitative science insightfulness and rigor of the HVTN 701 and 702 trial design and analysis for assessing immune correl; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | -287,488.00 | 40 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to provide general operating support for vaccine immunology statistical center and related projects; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -148,490.00 | 39 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to optimize and augment methods to identify mucosal immune factors that may contribute to HIV prevention and vaccine-induced protection.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -320,101.00 | 41 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to provide general operating support associated with the Vaccine Statistical Support platform; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -1,525,562.00 | 44 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to provide statistical support to generate novel analytic methods and tools, and clinical and pre-clinical trial design and analysis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 34,895,487.00 | 2 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to support a test of concept efficacy trial to determine if a novel experimental HIV vaccine prevents HIV infection in women in southern Africa who are at high risk for HIV infection.; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | -1,092,156.00 | 43 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to establish a vaccine immunology statistical center that will provide statistical and data management support to the Vaccine Discovery Centers; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,576,338.00 | 21 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to support the development and clinical evaluation of an HIV vaccine regimen, in the region of the globe most heavily burdened by the HIV epidemic, specifically clade C epidemic in Southern Africa; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | -2,595,322.00 | 45 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to carry out experimental studies in humans to determine if and how novel adjuvant and HIV-1 envelope immunogen combinations can induce higher levels, longer lasting, and qualitatively improved HIV-1 antibodies that may protect against HIV-1 acquisition; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 6,745,804.00 | 11 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to provide statistical support to generate novel analytic methods and tools, and clinical and pre-clinical trial design and analysis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,884,633.00 | 19 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to provide general operating support associated with the Vaccine Statistical Support platform; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 3,911,293.00 | 13 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to provide assistance in study design, assay development, data interpretation, and a data sharing portal to foundation grantees working to design candidate HIV vaccines and evaluate those vaccines in laboratory studies and clinical trials; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 15,144,268.00 | 5 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to provide statistical support and a data sharing portal to foundation grantees working to design candidate HIV vaccines and evaluate those vaccines in laboratory studies and clinical trials; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 63,676,225.00 | 1 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to support an efficacy trial of a candidate HIV vaccine in the Republic of South Africa to determine if this vaccine can improve upon the modest efficacy results obtained with a similar vaccine in the “RV144” trial conducted in Thailand.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 2,609,460.00 | 16 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to establish a vaccine immunology statistical center that will provide statistical and data management support to the Vaccine Discovery Centers; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 16,175,191.00 | 4 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to support the expeditious discovery of HIV vaccines with increased global relevance, effectiveness, efficiency, and accessibility; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 7,336,185.00 | 9 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to carry out experimental studies in humans to determine if and how novel adjuvant and HIV-1 envelope immunogen combinations can induce higher levels, longer lasting, and qualitatively improved HIV-1 antibodies that may protect against HIV-1 acquisition; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 4,802,089.00 | 12 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to support the development and clinical evaluation of an HIV vaccine regimen, in the region of the globe most heavily burdened by the HIV epidemic, specifically clade C epidemic in Southern Africa; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 938,885.00 | 25 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to provide general operating support for vaccine immunology statistical center and related projects; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 474,566.00 | 26 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to facilitate and speed the development and licensure of a safe, effective prophylactic HIV-1 vaccine that can be globally deployed to halt the HIV-1 pandemic; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -474,566.00 | 42 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to establish a vaccine immunology statistical center that will provide statistical and data management support to the Vaccine Discovery Centers; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 3,084,907.00 | 14 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to establish a vaccine immunology statistical center that will provide statistical and data management support to the Vaccine Discovery Centers; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,051,333.00 | 23 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to develop methods and computational tools in biostatistics, computational biology, and mathematical modeling that will improve the quantitative science insightfulness and rigor of the HVTN 701 and 702 trial design and analysis for assessing immune correl; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 7,146,511.00 | 10 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to increase capacity to conduct HIV vaccine clinical trials, including licensure trials, in highly impacted populations in clade C region of southern Africa.; Aid type: Other technical assistance. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 2,989,361.00 | 15 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to optimize and augment methods to identify mucosal immune factors that may contribute to HIV prevention and vaccine-induced protection.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 700.00 | 34 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | for general operating support. 2013 Obliteride. Investment start date: 9/19/2013 to end date: 10/3/2013. Grantee name: Fred Hutchinson Cancer Research Center; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected countries: United states of america (the). | |
| Bill and Melinda Gates Foundation | 1,697,205.00 | 20 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to facilitate and speed the development and licensure of a safe, effective prophylactic HIV-1 vaccine that can be globally deployed to halt the HIV-1 pandemic; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 998,330.00 | 24 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to establish a vaccine immunology statistical center that will provide statistical and data management support to the Vaccine Discovery Centers; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 8,000,000.00 | 8 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to establish a vaccine immunology statistical center that will provide statistical and data management support to the Vaccine Discovery Centers; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,157,694.00 | 22 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to facilitate and speed the development and licensure of a safe, effective prophylactic HIV-1 vaccine that can be globally deployed to halt the HIV-1 pandemic; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| DonorsTrust | 250.00 | 36 | -- | http://conservativetransparency.org/donor/donorstrust/ | -- | ||
| Bill and Melinda Gates Foundation | 100,000.00 | 28 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to identify inhibitors of a bacterial DNA repair enzyme that allows tuberculosis to mutate. Identifying these inhibitors could lead to therapies that kill bacteria and limit drug resistance.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| DonorsTrust | 250.00 | 36 | -- | http://conservativetransparency.org/donor/donorstrust/ | -- | ||
| Bill and Melinda Gates Foundation | 100,000.00 | 28 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to develop a library of media compounds needed to optimize in vitro production of infective malaria sporozites needed for use in an effective vaccine; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| DonorsTrust | 500.00 | 35 | -- | http://conservativetransparency.org/donor/donorstrust/ | -- | ||
| Bill and Melinda Gates Foundation | 11,879,298.00 | 6 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to elucidate the innate and adaptive immune responses that can protect against HIV-1 infection at all ages; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 400,000.00 | 27 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to convene the annual AIDS Vaccine 2007 International Conference. AIDS Vaccine Conference 2007. Investment start date: 12/1/2006 to end date: 12/1/2007. Grantee name: Fred Hutchinson Cancer Research Center; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -44,455.68 | 38 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to convene the annual AIDS Vaccine 2007 International Conference. AIDS Vaccine Conference 2007. Investment start date: 12/1/2006 to end date: 12/1/2007. Grantee name: Fred Hutchinson Cancer Research Center; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 2,500,000.00 | 17 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to provide global health research pilot-project funding to non-government organizations in King County, Washington to attract new investigators, research and collaboration in the Puget Sound community; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 2,000,000.00 | 18 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to provide global health research pilot-project funding to non-government organizations in King County, Washington to attract new investigators, research and collaboration in the Puget Sound community; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 9,945,896.00 | 7 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to establish a Vaccine Immunology Statistical Center (VISC) to provide statistical and data management support to the Vaccine Discovery Centers; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 30,072,500.00 | 3 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to improve HIV vaccines that can control the AIDS epidemic. Harnessing Innate Immunity to Enhance the Immunogenicity of T-Cell Inducing HIV Vaccines. Investment start date: 8/1/2006 to end date: 7/31/2013. Grantee name: Fred Hutchinson Cancer Research Cen; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| MacArthur Foundation | 25,000.00 | 32 | FIXME | https://www.macfound.org/grants/ | -- | To support a research project on molecular biology of parasitic diseases. Affected countries: United States; affected states: Washington; affected cities: Seattle. | |
| MacArthur Foundation | 25,000.00 | 32 | FIXME | https://www.macfound.org/grants/ | -- | To support research on the role of scavenged host glycolipids in the autoimmune neuropathology of Chagas disease. Affected countries: United States; affected states: Washington; affected cities: Seattle. |